BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 2580438)

  • 41. Elevated titers of the beta subunit of human chorionic gonadotropin in oophorectomized women being treated for trophoblastic disease.
    Hatch KD; Shingleton HM; Younger B; Boots LR
    Am J Obstet Gynecol; 1980 May; 137(1):122-6. PubMed ID: 7369275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molar pregnancy in British Columbia: estimated incidence and postevacuation regression patterns of the beta subunit of human chorionic gonadotropin.
    Yuen BH; Cannon W
    Am J Obstet Gynecol; 1981 Feb; 139(3):316-9. PubMed ID: 7468701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review.
    Çekmez Y; Haberal ET; Ulu İ; Gülşen S
    BJOG; 2016 Sep; 123(10):1706. PubMed ID: 27531332
    [No Abstract]   [Full Text] [Related]  

  • 44. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels.
    Uberti EMH; Diaz RKE; Cardoso RB; Braga A
    Rev Bras Ginecol Obstet; 2020 May; 42(5):240-247. PubMed ID: 32483804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydatidiform mole: clinical analysis of 310 patients.
    Mungan T; Kuşçu E; Dabakoğlu T; Senöz S; Uğur M; Cobanoglu O
    Int J Gynaecol Obstet; 1996 Mar; 52(3):233-6. PubMed ID: 8775674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
    Goldberg GL; Cloete K; Bloch B; Wiswedel K; Altaras MM
    Br J Obstet Gynaecol; 1987 Jan; 94(1):22-5. PubMed ID: 2434125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hormonal contraception after evacuation of hydatid mole (author's transl)].
    Donát J; Chalupa M
    Cesk Gynekol; 1981 May; 46(4):286-9. PubMed ID: 7249096
    [No Abstract]   [Full Text] [Related]  

  • 51. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
    Murad TM; Longley JV; Lurain JR; Brewer JI
    Int J Gynaecol Obstet; 1990 Aug; 32(4):359-67. PubMed ID: 1977631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of hydatidiform mole and choriocarcinoma.
    Bracken MB; Brinton LA; Hayashi K
    Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
    Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
    Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
    Quigley MM; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.